Revvity, Inc. (NYSE:RVTY) Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC lessened its stake in Revvity, Inc. (NYSE:RVTY) by 3.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 151,374 shares of the company’s stock after selling 5,856 shares during the period. Corient Private Wealth LLC’s holdings in Revvity were worth $16,895,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Envestnet Portfolio Solutions Inc. boosted its stake in shares of Revvity by 40.7% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 4,102 shares of the company’s stock worth $458,000 after buying an additional 1,186 shares during the period. one8zero8 LLC acquired a new stake in shares of Revvity during the fourth quarter worth about $3,511,000. Natixis Advisors LLC boosted its stake in shares of Revvity by 14.7% during the fourth quarter. Natixis Advisors LLC now owns 14,339 shares of the company’s stock worth $1,600,000 after buying an additional 1,840 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Revvity by 33.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company’s stock worth $58,000 after buying an additional 131 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of Revvity by 8.6% during the fourth quarter. Sequoia Financial Advisors LLC now owns 25,929 shares of the company’s stock worth $2,894,000 after buying an additional 2,064 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Insider Transactions at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now owns 33,400 shares in the company, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the firm’s stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the sale, the insider now owns 19,652 shares in the company, valued at approximately $2,295,550.12. This trade represents a 21.84 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on RVTY. Raymond James reiterated an “outperform” rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. KeyCorp raised their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price objective for the company. in a research report on Friday, January 10th. Barclays raised their price objective on shares of Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Finally, Bank of America upgraded shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price objective for the company in a research report on Friday, December 13th. Four research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $136.25.

Revvity Trading Down 2.5 %

Shares of Revvity stock opened at $109.88 on Thursday. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The stock has a market cap of $13.20 billion, a PE ratio of 49.72, a price-to-earnings-growth ratio of 3.82 and a beta of 1.06. The company has a 50-day moving average of $116.76 and a two-hundred day moving average of $117.74.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the business posted $1.25 earnings per share. On average, research analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.25%. Revvity’s dividend payout ratio (DPR) is 12.67%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.